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The feasibility of in vivocoronary angioscopy was tested
utilizing a 1.8 mm angioscope in vesselswhere blood had
been replaced by optically clear liquids, including a new
perfluorocarbon emulsion. After trials in postmortem
canine and human coronary arteries, in vivo intralum-
inal visualization was accomplished in the dog with a
At present, the primary diagnostic method for evaluating
coronary anatomy in humans beings is selective coronary
angiography. Although this method delineates the coronary
lumen with reasonable accuracy , it allows recognition of
pathologic changes principally by identifying filling defects.
Direct visualization of the internal surface of coronary ar-
teries would permit not only precise determination of coro-
nary cross-sectional area, but also identification of different
types of vascular disease (for example, thrombus versus
atheroma) . The major barriers to in vivo visualization of
coronary arteries in the past include the opacity of blood to
visible light and the large size of commercially available
fiberoptic scopes relative to coronary artery dimensions (l,2).
The recent development of a high resolution 1.8 mm fiber-
optic scope, as well as a translucent perfluorocarbon emul-
sion blood substitute, has made prolonged in vivo visual-
ization of the coronary arteries possible. In this report , we
describe our initial studies during the development of this
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catheterization technique and in patients during open
heart surgery. The results demonstrate the feasibility
and potential clinical usefulness of direct visualization
of intravascular anatomy and disease, analogous to en-
doscopy of other organ systems.
technique , progressing from in vitro studies of postmortem
hearts to in vivo studies of canine and human coronary
arteries.
Methods
Description of angioscope. The prototype Olympus ul-
trathin fiberscope used in this study has an external diameter
of 1.8 mm and consists of two separate fiberoptic bundles .
One bundle transmits light from an external source through
the fiberscope into the vessel being examined and the second
bundle, the image guide, transmits the reflected image back
to an adjustable eyepiece. To reduce the outer diameter of
this prototype unit to 1.8 mm, the angulation system and
channels usually provided in endoscopes were not included .
Illumination was provided by an Olympus ILK-3 150 watt
halogen light source. Photography was accomplished by
using a special endoscopic camera adapter that was attached
to the eyepiece of the endoscope and then fitted to the OM-
2 camera body. The standard ground glass focusing screen
was replaced by a special Fresnel lens focusing screen de-
signed exclusively for endoscopy . With this photographi c
system, we were able to perform the endoscopic procedure
through the viewfinder of the 35 mm camera, taking picture s
whenever appropriate.
Description of perfluorocarbon emulsion. A new
translucent perfluorocarbon emulsion blood substitute has
recently been produced by one of us (R.P .G.) . Perfluoro-
carbon-containing blood replacement preparations can pro-
vide both oxygen transport and maintenance of oncotic pres-
sure (3-5). These compounds must be emulsified, but the
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resulting emulsions are usually fairly turbid. This turbidity
would interfere with intravascular visualization by means
of fiberoptics; therefore, it is necessary to utilize prepara-
tions that are as low in turbidity as possible. By means of
sonication using suitable emulsifying agents and perfluo-
rocarbons, the translucent perfluorocarbon-containing blood
replacement preparation was made. As in previous studies,
electrolytes and an oncotic agent such as hydroxyethyl starch
were added. The completed preparation was sterilized by
filtration and equilibrated with a mixture of 95% oxygen
and 5% carbon dioxide, and the pH was adjusted to 7.45.
Postmortem studies. Studies were initially conducted
on postmortem canine and human hearts from which blood
had been washed out with normal saline solution. Structures
within the left ventricle were viewed with the fiberscope
which had been passed retrograde across the aortic valve.
An 8 French Cordis sheath was used to gain access to the
left main coronary artery. The vessel was perfused at phys-
iologic pressures with either saline solution or the perfluo-
rocarbon emulsion by way of the sidearm of the sheath. The
angioscope was then passed through the rubber diaphragm
of the Cordis sheath into the left coronary artery orifice.
Selective angioscopy of the proximal segments of the cir-
cumflex and anterior descending coronary arteries was then
performed.
In vivo canine studies. Adult mongrel dogs weighing
20 to 25 kg were anesthetized with morphine sulfate and
chloralose, intubated and then ventilated with a Harvard
respiratory pump. Cutdown procedures were performed over
both carotid arteries. A thoracotomy was performed over
the left lateral chest and the heart was suspended in a peri-
cardial cradle. A 7 French NIH cathether was placed in the
descending aorta for measurement of arterial pressure. A
21 gauge angiocatheter was inserted into a distal branch of
the left anterior descending coronary artery. Arterial and
intracoronary pressures were measured with Statham P23D6
strain gauges and recorded on an Electronics for Medicine
multichannel photographic recorder.
A 10 French guiding catheter was constructed to facilitate
entrance of the fiberscope into the left main coronary artery.
After insertion into the carotid artery, the tip of the guiding
catheter was advanced to the left main coronary artery under
fluoroscopy. Ifdistal coronary artery pressure decreased as
a result of ostial obstruction by the guiding catheter, per-
fusion of the left coronary artery could be achieved by
autotransfusion through a connection to the proximal end
of the NIH catheter. After insertion of the fiberscope in all
dogs, visualization was achieved by sheath sidearm infusion
of either oxygenated Krebs-Ringer's solution or the per-
fluorocarbon emulsion, both of which were maintained at
37°C before injection.
In vivo human studies. Informed consent was obtained
from all patients in whom coronary angioscopy was at-
tempted. In one patient undergoing coronary artery bypass
graft surgery, angioscopy was performed after completion
of the distal anastomosis of the saphenous vein graft to the
left anterior descending coronary artery. Through a side
branch of the vein graft, the angioscope was advanced across
the distal anastomosis and into the native coronary artery.
In three additional patients, the angioscope was advanced
anterograde into the left anterior descending coronary artery
directly through the arteriotomy. Intraluminal visualization
was achieved in each patient with the aid of the translucent
cardioplegic solution normally used to perfuse the vein grafts
and coronary arteries.
Results
Postmortem canine studies. Initial development of the
angioscopic technique involved studies in postmortem ca-
nine hearts in which details of light source and intensity,
photographic technique and catheter manipulation could be
investigated in a totally controlled setting. Figures 1 and 2
illustrate the detail and photographic quality of images of
the mitral valve commissure (Fig. 1) and papillary muscles
with chordae (Fig. 2) obtained in the postmortem saline-
filled heart. The black spots in these and the other figures
represent broken optical fibers that were not transmitting
the reflected image back to the observer and external camera.
Figure 3 shows the lumen of the left anterior descending
artery (viewed from the aortic orifice of the left coronary
artery) in a postmortem canine heart using similar techniques.
In vivo canine studies. After successfully defining the
technical factors necessary to obtain photographic images
under ideal static conditions (Fig. lA, B and C), we pro-
ceeded to in vivo studies of the normal canine coronary
vasculature using oxygenated Ringer's lactate solution and
perfluorocarbon solution. Figures ID and IE show the in-
ternal (lumen) surface of the left coronary artery in anes-
thetized dogs; these photographs were taken through the
ultrathin angioscope that had been advanced by a guiding
catheter into the ostium of the left coronary artery. The ostia
of arterial branches of the left coronary artery are clearly
visible.
Clinical studies. After completion of the in vivo canine
studies, we studied four patients during the course of coro-
nary artery bypass graft surgery. Figure 1F shows an ath-
erosclerotic plaque within the lumen of the left anterior
descending artery in one of these patients, after the ultrathin
angioscope was passed into the artery by way of a side
branch of the saphenous vein graft. The plaque appears
white and is raised from the wall, partially occluding the
vessel lumen.
Discussion
The development of an ultrathin fiberoptic instrument
(6-8) has made possible the intraluminal visualization of
coronary arteries in vivo. Replacement of intraarterial blood
IN VIVO CORONARY ANGlOSCOPY J AM Call CARDIOl
1983.1(5).1311-4
1313
Figure 1. A, Mitral valve commissure as viewed from left ventricle of postmortem canine heart
filled with normal saline solution. B, Canine anterior-superior papillary muscle and chordae ten-
dineae in postmortem left ventricle filled with normal saline solution. C, Left anterior descending
coronary artery, filled with normal saline solution in postmortem canine heart. D, In vivo view of
trifurcation of left coronary artery into (from left to right) circumflex, intermediate and anterior
descending branches in the dog during perfusion with oxygenated Krebs-Ringer's solution. E, In
vivo view of bifurcation of left mainstem coronary artery into circumflex (left) and anterior de-
scending (right) branches during injection of perfluorocarbon emulsion into canine coronary artery.
F, In vivo view of human left anterior descending coronary artery lumen showing encroachment
by atherosclerotic plaque. Blood replacement with cardioplegic solution permitted intraluminal
visualization.
with clear liquids such as simple crystalloid solutions or a
recently developed translucent perfluorocarbon emulsion is
necessary. Perfluorocarbon emulsions have been used for
transfusion in patients with a remarkable lack of significant
side effects (9) and are currently being tested in clinical
trials. Moreover, they have been shown experimentally to
have a protective effect on ischemic myocardium (10) and
to be efficacious when used for total cardiopulmonary by-
pass (11). However, a rare idiosyncratic adverse pulmonary
reaction, which appeared to be immunologic in origin and
was successfully treated with corticosteriods and diphen-
hydramine, was recently reported (12).
Clinical applications. There are numerous potential ap-
plications of coronary angioscopy. The principal current
method for evaluation of human coronary anatomy is coro-
nary angiography, which defines accurately the lumen of
the coronary vessels but recognizes pathologic changes prin-
cipally by identifying filling defects. The nature of these
defects (for example, atheroma, thrombus, plaque, hem-
orrhage) frequently cannot be determined by the coronary
angiogram; moreover, the cardiac surgeon performing by-
pass surgery is rarely able to provide information concerning
the nature of the coronary obstructions that prompted the
operative procedure. Coronary angioscopy at the time of
diagnostic cardiac catheterization or during cardiac surgery,
or both, should provide important information regarding the
nature of the underlying disease process.
During cardiac catheterization, it may also be possible
to differentiate atheroma from residual thrombus in patients
undergoing fibrinolytic treatment for acute myocardial in-
farction (13). Insight may be gained into the mechanism of
abrupt reclosure in patients undergoing percutaneous trans-
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luminal coronary angioplasty (14,15). Cardiac surgeons
may find the angioscope useful as a means for evaluating
the patency of vein graft anastomoses to coronary arteries
during open heart surgery. In addition, preliminary studies
with lasers on artherosclerotic plaques (16) raise the pos-
sibility of laser-mediated "atheroplasty" under direct vis-
ualization, if this modality can be coupled to a miniature
fiberscope.
Riskof adverse effects. Even though no untoward effect
from coronary angioscopy was observed in any of the human
or dog studies, instrumentation of coronary arteries with the
angioscope is likely to carry a finite risk, although small,
of an adverse effect, such as provocation of coronary spasm,
dissection or perforation. Until the incidence and severity
of potential risks are better defined, coronary angioscopy
should be performed only under a research protocol by ex-
perienced angiographers skilled in techniques of catheter
manipulation and at centers where potential complications
can be treated immediately. In this regard, because the po-
tential risks are not yet defined, it is unknown whether an
attempt to obtain additional diagnostic information with an-
gioscopy during surgery or cardiac catheterization is war-
ranted clinically. Moreover, it should be emphasized that
visualization of the lumen is currently limited to proximal
coronary artery segments because of the lack of an angu-
lation mechanism in the fiberscope.
In this study, we reported on the development of meth-
odology for coronary angioscopy and documented its prac-
tical application in patients undergoing cardiac surgery. The
in vivo canine studies have encouraged us to believe that
similar studies of human coronary anatomy may be possible
at the time of diagnostic cardiac catheterization, and efforts
are currently underway to test appropriate guiding catheters
to facilitate coronary angioscopy in patients.
We gratefully acknowledge the expert technical assistance of Robert Lowe
and Deborah Shropshire in the performance of the canine studies.
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